Coumermycin A1

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Coumermycin A1
Accession Number
DB13912
Description
Not Available
Type
Small Molecule
Groups
Experimental
Structure
Thumb
Weight
Average: 1110.092
Monoisotopic: 1109.37533932
Chemical Formula
C55H59N5O20
Synonyms
  • Coumamycin
  • Coumermycin
  • Notomycin A1

Pharmacology

Indication
Not Available
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcetohexamideThe therapeutic efficacy of Acetohexamide can be increased when used in combination with Coumermycin A1.
ChlorpropamideThe therapeutic efficacy of Chlorpropamide can be increased when used in combination with Coumermycin A1.
Darbepoetin alfaThe risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Coumermycin A1.
DexmethylphenidateThe serum concentration of the active metabolites of Coumermycin A1 can be increased when Coumermycin A1 is used in combination with Dexmethylphenidate.
ErythropoietinThe risk or severity of Thrombosis can be increased when Erythropoietin is combined with Coumermycin A1.
GliclazideThe therapeutic efficacy of Gliclazide can be increased when used in combination with Coumermycin A1.
GlimepirideThe therapeutic efficacy of Glimepiride can be increased when used in combination with Coumermycin A1.
GlipizideThe therapeutic efficacy of Glipizide can be increased when used in combination with Coumermycin A1.
GliquidoneThe therapeutic efficacy of Gliquidone can be increased when used in combination with Coumermycin A1.
GlyburideThe therapeutic efficacy of Glyburide can be increased when used in combination with Coumermycin A1.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

Products

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as coumarin glycosides. These are aromatic compounds containing a carbohydrate moiety glycosidically bound to a coumarin moiety.
Kingdom
Organic compounds
Super Class
Phenylpropanoids and polyketides
Class
Coumarins and derivatives
Sub Class
Coumarin glycosides
Direct Parent
Coumarin glycosides
Alternative Parents
Phenolic glycosides / 4-hydroxycoumarins / O-glycosyl compounds / 1-benzopyrans / 2-heteroaryl carboxamides / Pyrrole carboxamides / Pyranones and derivatives / Substituted pyrroles / Benzenoids / Dicarboxylic acids and derivatives
show 17 more
Substituents
1-benzopyran / 2-heteroaryl carboxamide / 4-hydroxycoumarin / Acetal / Alcohol / Aromatic heteropolycyclic compound / Azacycle / Benzenoid / Benzopyran / Carboxamide group
show 36 more
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
Not Available

Chemical Identifiers

UNII
PCH9QZ1IIH
CAS number
4434-05-3
InChI Key
WTIJXIZOODAMJT-IYKSDEDASA-N
InChI
InChI=1S/C55H59N5O20/c1-21-12-16-29(57-21)48(67)77-42-38(63)52(79-54(6,7)44(42)71-10)73-31-18-14-26-36(61)34(50(69)75-40(26)24(31)4)59-46(65)28-20-56-33(23(28)3)47(66)60-35-37(62)27-15-19-32(25(5)41(27)76-51(35)70)74-53-39(64)43(45(72-11)55(8,9)80-53)78-49(68)30-17-13-22(2)58-30/h12-20,38-39,42-45,52-53,56-58,61-64H,1-11H3,(H,59,65)(H,60,66)/t38-,39-,42+,43+,44-,45-,52-,53-/m0/s1
IUPAC Name
(3S,4R,5S,6S)-5-hydroxy-6-[(4-hydroxy-3-{5-[(4-hydroxy-7-{[(2S,3S,4R,5S)-3-hydroxy-5-methoxy-6,6-dimethyl-4-(5-methyl-1H-pyrrole-2-carbonyloxy)oxan-2-yl]oxy}-8-methyl-2-oxo-2H-chromen-3-yl)carbamoyl]-4-methyl-1H-pyrrole-3-amido}-8-methyl-2-oxo-2H-chromen-7-yl)oxy]-3-methoxy-2,2-dimethyloxan-4-yl 5-methyl-1H-pyrrole-2-carboxylate
SMILES
CO[[email protected]]1[[email protected]](OC(=O)C2=CC=C(C)N2)[[email protected]](O)[[email protected]@H](OC2=C(C)C3=C(C=C2)C(O)=C(NC(=O)C2=C(C)C(=CN2)C(=O)NC2=C(O)C4=C(OC2=O)C(C)=C(O[[email protected]]2OC(C)(C)[[email protected]@H](OC)[[email protected]](OC(=O)C5=CC=C(C)N5)[[email protected]@H]2O)C=C4)C(=O)O3)OC1(C)C

References

General References
Not Available
PubChem Compound
54697785
PubChem Substance
347829332
ChemSpider
23287305
BindingDB
50048490
ChEMBL
CHEMBL389471
Wikipedia
Coumermycin_A1

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.0111 mg/mLALOGPS
logP4.59ALOGPS
logP4.39ChemAxon
logS-5ALOGPS
pKa (Strongest Acidic)5.21ChemAxon
pKa (Strongest Basic)-4ChemAxon
Physiological Charge-2ChemAxon
Hydrogen Acceptor Count16ChemAxon
Hydrogen Donor Count9ChemAxon
Polar Surface Area347.07 Å2ChemAxon
Rotatable Bond Count16ChemAxon
Refractivity281.22 m3·mol-1ChemAxon
Polarizability115.95 Å3ChemAxon
Number of Rings9ChemAxon
Bioavailability0ChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created on September 22, 2017 09:49 / Updated on June 12, 2020 10:53

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates